BR112013013960A8 - Composi%c3%87%c3%95es de vacinas de mal%c3%81ria, polipept%c3%8ddeos, fragmentos do mesmo, mol%c3%89culas de %c3%81cido nucleico, e usos destes - Google Patents

Composi%c3%87%c3%95es de vacinas de mal%c3%81ria, polipept%c3%8ddeos, fragmentos do mesmo, mol%c3%89culas de %c3%81cido nucleico, e usos destes

Info

Publication number
BR112013013960A8
BR112013013960A8 BR112013013960A BR112013013960A BR112013013960A8 BR 112013013960 A8 BR112013013960 A8 BR 112013013960A8 BR 112013013960 A BR112013013960 A BR 112013013960A BR 112013013960 A BR112013013960 A BR 112013013960A BR 112013013960 A8 BR112013013960 A8 BR 112013013960A8
Authority
BR
Brazil
Prior art keywords
fragments
vaccines
8ddeos
89nucleic
89cells
Prior art date
Application number
BR112013013960A
Other languages
English (en)
Other versions
BR112013013960A2 (pt
Inventor
Pfeil Johannes
Heiss Kiristen
Muller Ann-Kristin
Original Assignee
Univ Heidelberg Ruprecht Karls
MalVa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Heidelberg Ruprecht Karls, MalVa GmbH filed Critical Univ Heidelberg Ruprecht Karls
Publication of BR112013013960A2 publication Critical patent/BR112013013960A2/pt
Publication of BR112013013960A8 publication Critical patent/BR112013013960A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOSIÇÕES DE VACINAS DE MALÁRIA, POLIPEPTÍDEOS, FRAGMENTOS DO MESMO, MOLÉCULAS DE ÁCIDO NUCLEICO, E USOS DESTES. A presente invenção refere-se a polipeptídeos ou seus fragmentos para uso como vacinas de malária. Ela também refere-se a moléculas de ácido nucleico codificado os polipeptídeos da invenção. Ela ainda refere-se a composições compreendendo tais polipeptídeos ou seus fragmentos ou as moléculas de ácido nucleico, em particular combinações de tais polipeptídeos ou seus fragmentos, e uso de tais composições como vacinas de malária.
BR112013013960A 2010-12-06 2011-12-06 Composi%c3%87%c3%95es de vacinas de mal%c3%81ria, polipept%c3%8ddeos, fragmentos do mesmo, mol%c3%89culas de %c3%81cido nucleico, e usos destes BR112013013960A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41990610P 2010-12-06 2010-12-06
PCT/EP2011/006110 WO2012076157A2 (en) 2010-12-06 2011-12-06 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum

Publications (2)

Publication Number Publication Date
BR112013013960A2 BR112013013960A2 (pt) 2017-03-21
BR112013013960A8 true BR112013013960A8 (pt) 2017-12-05

Family

ID=45099026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013013960A BR112013013960A8 (pt) 2010-12-06 2011-12-06 Composi%c3%87%c3%95es de vacinas de mal%c3%81ria, polipept%c3%8ddeos, fragmentos do mesmo, mol%c3%89culas de %c3%81cido nucleico, e usos destes

Country Status (5)

Country Link
US (2) US20130323276A1 (pt)
EP (1) EP2648744B1 (pt)
CN (1) CN103491979B (pt)
BR (1) BR112013013960A8 (pt)
WO (1) WO2012076157A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011066995A1 (en) * 2009-12-05 2011-06-09 Universität Heidelberg Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins
JP2018508481A (ja) * 2015-02-02 2018-03-29 ザ ユニバーシティ オブ バーミンガム 複数のｔ細胞エピトープを有する標的化部分ペプチドエピトープ複合体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672290B1 (fr) 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
FR2735478B1 (fr) 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme
WO2011066995A1 (en) * 2009-12-05 2011-06-09 Universität Heidelberg Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins

Also Published As

Publication number Publication date
EP2648744B1 (en) 2020-06-03
WO2012076157A3 (en) 2013-03-28
WO2012076157A2 (en) 2012-06-14
US10548960B2 (en) 2020-02-04
CN103491979A (zh) 2014-01-01
BR112013013960A2 (pt) 2017-03-21
CN103491979B (zh) 2016-12-21
US20130323276A1 (en) 2013-12-05
WO2012076157A8 (en) 2020-01-30
US20170072039A1 (en) 2017-03-16
EP2648744A2 (en) 2013-10-16

Similar Documents

Publication Publication Date Title
PH12015502553A1 (en) Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
AR113177A2 (es) Polipéptidos que tienen actividad de lisozima y polinucleótidos que los codifican
BR112014032316A2 (pt) proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
BR112018000604A2 (pt) moléculas de anticorpo que ligam cd45
CL2013000322A1 (es) Compuestos derivados de piperidina sustituida; proceso de preparacion; composicion farmaceutica y su uso para producir un efecto antiproliferativo y/o proapoptotico.
CO6470854A2 (es) Variantes de celulasa con expresión, actividad y/o estabilidad mejoradas, y uso de las mismas
BR112013003825A2 (pt) conjugados, partículas, composições e métodos relacionados
BR112013009083A2 (pt) anticorpos humanos de oncostatin m e métodos de uso
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
BR112014002817A2 (pt) Uso de um polipeptídeo p62, ou de um ácido nucleico que codifica p62
MX2021010668A (es) Proteinas de fusion de citoquinas.
BR112017019412A2 (pt) proteínas ligadoras de tslp
BR112015011244A2 (pt) Análogos de compstatina de ação prolongada, método de fabricação e uso dos mesmos, bem como composição de qualidade farmacêutica
MX2013012844A (es) Secuencias de aminoacidos dirigidas contra il-17a, il-17f y/o il-17a/f y polipeptidos que comprenden las mismas.
BR112012007234A2 (pt) combinação farmacêutica compreendendo inibidor de dpp-4 e metformina, bem como seu uso e seu processo de preparação
BR112013005855A2 (pt) heteroarilas fundidas e seus usos
AR073088A1 (es) Anticuerpos anti-il-13 obtenidos mediante ingenieria composiciones metodos y usos
BR112014026740A8 (pt) anticorpo, composição, método para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
TN2014000360A1 (en) Cx3cr1-binding polypeptides
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
BR112013003522A8 (pt) "polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, uso, método de preparação, bem como ácido nucleico codificando os mesmos"
CL2012002879A1 (es) Proteína recombinante robo1-fc que comprende el dominio extracelular de la isoforma b de la proteína robo1 o una parte de este dominio, un conector y un dominio fc de una inmunoglobulina; molécula de ácido nucleico que la codifica; composición farmacéutica que la comprende; y su uso como herramienta de diagnóstico para detectar la sobreexpresión de una molécula de la familia slit en un paciente.
BR112013003722A2 (pt) produtos para cuidado e métodos de uso e fabricação dos mesmos
WO2014076321A8 (en) Novel specific-binding polypeptides and uses thereof
BR112012021545A2 (pt) composições cdv recombinantes e seus usos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MALVA GMBH (DE)

B25G Requested change of headquarter approved

Owner name: MALVA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: MALVA GMBH (DE)

B25G Requested change of headquarter approved

Owner name: MALVA GMBH (DE)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements